Adawi Kamal bought FATE
October 20, 2025 · Form 4 insider transaction
Adawi Kamal bought 75,000 shares of Fate Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderAdawi Kamal
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 20, 2025
Filing dateOctober 21, 2025
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Award of restricted stock units that vest with respect to 1/4th of the underlying shares on each of November 1, 2026, November 1, 2027, November 1, 2028, and November 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.